JLE

Hépato-Gastro & Oncologie Digestive

MENU

Faut-il poursuivre le dépistage du cancer colorectal après 75 ans ? Volume 26, numéro 9, Novembre 2019

  • [1] Mandel J.S., Bond J.H., Church T.R. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
  • [2] Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. JAMA 2001 ; 285 : 2750-6.
  • [3] Ko CW, Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology 2005 ; 129 : 1163-70.
  • [4] van Ballegooijen M, Habbema JDF, Boer R, et al. A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population. Rockville : Agency for Healthcare Research and Quality (US) ; 2003. Disponible à l’adresse suivante : https://www.ncbi.nlm.nih.gov/books/NBK285640/.
  • [5] Lewis C.L., Kistler C.E., Amick H.R. Older adults’ attitudes about continuing cancer screening later in life: A pilot study interviewing residents of two continuing care communities. BMC Geriatr. 2006;6:10.